Drawing for ACCELERATING PERFORMANCE

USPTO serial 98784269

ACCELERATING PERFORMANCE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RICHARDS, LESLIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACCELERATING PERFORMANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori P. Hager

Lori P. Hager Kyberia Legal, LLC88 South Finley Ave.2nd Fl., Suite ABasking Ridge, NJ 07920

Goods and services

ClassDescriptionStatusFirst use
035Advertising agencies specializing in pharmaceutical branding, product launch and consulting; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video, and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development in the field of pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 21, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 20, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 18, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 21, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 21, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 15, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 23, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Dec 19, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 19, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 19, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 6, 2024DOCKASSIGNED TO EXAMINER—
Oct 3, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance